The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

Share on Pinterest A new study shows GLP-1 drugs liraglutide ... Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

The problem was resolved Thursday, when lawmakers sent a $240 million supplemental budget to Governor Maura Healey, which she ...

That's according to the study funded by ... taking semaglutide. The GLP-1 drugs have become increasingly popular, with at least 1 in 8 U.S. adults reporting their use, according to a 2024 survey ...

Semaglutide and other GLP-1 agonists ... The study's limitations include the use of self-reported data and the lack of a control group. Dr. Gudbergsen concludes, "Our results show that by giving ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs receive a prescription for it, according to a new study from ... like peptide-1 (GLP-1) agonists are ...

Early animal studies have indicated that GLP-1 drugs can help cut alcohol cravings, but studies involving humans are only starting to emerge, researchers said. For this study, researchers tracked ...